vs
ConnectOne Bancorp, Inc.（CNOB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
ConnectOne Bancorp, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$115.6M vs $75.5M），过去两年ConnectOne Bancorp, Inc.的营收复合增速更高（32.5% vs 31.3%）
原公民共和银行控股公司是公民银行的母公司，总部位于密歇根州弗林特市。该公司曾在密歇根、威斯康星和俄亥俄三州运营219家分行与248台自动取款机，2013年6月与第一美德银行合并，第一美德后于2016年被亨廷顿银行控股收购。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CNOB vs PBYI — 直观对比
营收规模更大
CNOB
是对方的1.5倍
$75.5M
两年增速更快
CNOB
近两年复合增速
31.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $75.5M |
| 净利润 | $37.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 32.7% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 86.8% | — |
| 每股收益（稀释后） | $0.72 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNOBPBYI
| Q1 26 | $115.6M | — | ||
| Q4 25 | $112.6M | $75.5M | ||
| Q3 25 | $121.4M | $54.5M | ||
| Q2 25 | $84.1M | $52.4M | ||
| Q1 25 | $70.2M | $46.0M | ||
| Q4 24 | $68.5M | $59.1M | ||
| Q3 24 | $65.6M | $80.5M | ||
| Q2 24 | $65.8M | $47.1M |
净利润CNOBPBYI
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $41.0M | $8.8M | ||
| Q2 25 | $-20.3M | $5.9M | ||
| Q1 25 | $20.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $17.2M | $20.3M | ||
| Q2 24 | $19.1M | $-4.5M |
毛利率CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | 22.7% | ||
| Q3 25 | 47.2% | 17.6% | ||
| Q2 25 | -30.1% | 12.7% | ||
| Q1 25 | 39.0% | 8.7% | ||
| Q4 24 | 38.6% | 22.6% | ||
| Q3 24 | 35.3% | 27.4% | ||
| Q2 24 | 39.1% | -4.6% |
净利率CNOBPBYI
| Q1 26 | 32.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 33.7% | 16.2% | ||
| Q2 25 | -24.1% | 11.2% | ||
| Q1 25 | 28.8% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.2% | 25.2% | ||
| Q2 24 | 28.9% | -9.6% |
每股收益（稀释后）CNOBPBYI
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.88 | $0.26 | ||
| Q3 25 | $0.78 | $0.17 | ||
| Q2 25 | $-0.52 | $0.12 | ||
| Q1 25 | $0.49 | $0.06 | ||
| Q4 24 | $0.48 | $0.40 | ||
| Q3 24 | $0.41 | $0.41 | ||
| Q2 24 | $0.46 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $344.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.6B | $130.3M |
| 总资产 | $14.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CNOBPBYI
| Q1 26 | $344.5M | — | ||
| Q4 25 | $380.9M | $97.5M | ||
| Q3 25 | $542.7M | $94.4M | ||
| Q2 25 | $596.5M | $96.0M | ||
| Q1 25 | $292.6M | $93.2M | ||
| Q4 24 | $356.5M | $101.0M | ||
| Q3 24 | $247.2M | $96.7M | ||
| Q2 24 | $293.5M | $96.8M |
总债务CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益CNOBPBYI
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.2B | $92.1M | ||
| Q3 24 | $1.2B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M |
总资产CNOBPBYI
| Q1 26 | $14.2B | — | ||
| Q4 25 | $14.0B | $216.3M | ||
| Q3 25 | $14.0B | $202.9M | ||
| Q2 25 | $13.9B | $194.9M | ||
| Q1 25 | $9.8B | $196.2M | ||
| Q4 24 | $9.9B | $213.3M | ||
| Q3 24 | $9.6B | $220.7M | ||
| Q2 24 | $9.7B | $205.0M |
负债/权益比CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $106.4M | $14.4M | ||
| Q3 25 | $37.4M | $9.7M | ||
| Q2 25 | $6.5M | $14.1M | ||
| Q1 25 | $14.9M | $3.6M | ||
| Q4 24 | $60.7M | $15.6M | ||
| Q3 24 | $-14.4M | $11.0M | ||
| Q2 24 | $22.3M | $1.0M |
自由现金流CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | $14.4M | ||
| Q3 25 | $33.9M | $9.7M | ||
| Q2 25 | $6.4M | $14.1M | ||
| Q1 25 | $14.6M | $3.6M | ||
| Q4 24 | $56.9M | $15.6M | ||
| Q3 24 | $-15.6M | $11.0M | ||
| Q2 24 | $22.2M | $1.0M |
自由现金流率CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 89.7% | 19.1% | ||
| Q3 25 | 27.9% | 17.7% | ||
| Q2 25 | 7.6% | 26.8% | ||
| Q1 25 | 20.8% | 7.7% | ||
| Q4 24 | 83.1% | 26.4% | ||
| Q3 24 | -23.8% | 13.7% | ||
| Q2 24 | 33.7% | 2.1% |
资本支出强度CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 1.9% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% |
现金转化率CNOBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.91× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.74× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.84× | 0.54× | ||
| Q2 24 | 1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNOB
| Net Interest Income | $108.8M | 94% |
| Noninterest Income | $6.8M | 6% |
PBYI
暂无分部数据
